Irvine, Calif. - Sweat has a new enemy. Botox (botulinum toxin type A), developed by Allergan, has been approved by the U.S. Food and Drug Administration (FDA) to treat hyperhidrosis.
New Technology Could Allow Us to Rethink Alopecia Scores
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Treating Body Dysmorphic Disorder in Cosmetic Patients
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Sofwave Precise SUPERB Applicator FDA Cleared for Improving Facial Lines, Wrinkles
Methotrexate, Low-Dose Prednisone Efficacious in Alopecia Treatment
2 Clarke Drive Cranbury, NJ 08512